FDA issues PML warning for MS patients taking Gilenya
FDA issues PML warning for MS patients taking Gilenya
Following reports of progressive multifocal leukoencephalopathy among patients taking Gilenya for multiple sclerosis, the FDA has issued a warning of possible infection for those prescribed the immunosuppressant drug.... Read More - http://www.ms-uk.org/gilenya
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 5 Replies
- 11780 Views
-
Last post by gibbledygook
-
- 4 Replies
- 2262 Views
-
Last post by JohnC777
-
- 0 Replies
- 1343 Views
-
Last post by frodo
-
- 0 Replies
- 1389 Views
-
Last post by NHE
-
- 0 Replies
- 2093 Views
-
Last post by frodo